logo
Study finds 65% decline in urban bee population, heat and land use are main culprits

Study finds 65% decline in urban bee population, heat and land use are main culprits

Yahoo12-05-2025

Across the globe, the diversity of insect species and their populations are falling rapidly. A few research studies have gone as far as to estimate insect biomass has nearly halved since the 1970s. Bees are particularly hard-hit, suffering from habitat loss driven by agriculture and urban development, compounded by the growing effects of climate change.
A latest study conducted by a team of scientists from Julius-Maximilians-Universität Würzburg (JMU) in Germany analyzed the combined effects of land use and rising temperatures on insects at 179 sites across Bavaria. Their research, part of the LandKlif project within the Bavarian Climate Research Network (bayklif), was led by Professor Ingolf Steffan-Dewenter, with the findings published in the Proceedings of the Royal Society B: Biological Sciences.
The findings indicated that insects inhabiting different trophic levels react differently to the combination of increased temperatures and extensive land use. While bee populations in forests are able to withstand the heat, those in urban areas saw a staggering 65% decline. Similar to humans, bees are impacted not just by high daytime temperatures but also by warmer-than-average nights.
According to biologist Dr. Cristina Ganuza, from the Department of Animal Ecology and Tropical Biology at JMU, the impact of night-time temperatures on diurnal insects is particularly significant. This is due to the fact that average night-time temperatures are rising faster than daytime temperatures, further stressing insect populations.
Although insects higher up the food chain managed better with the heat, populations faced challenges in open agricultural habitats. "This can have a negative impact on agricultural production because insects that contribute to natural pest control should be similarly affected," said Dr. Sarah Redlich, research fellow at JMU's Department of Animal Ecology and Tropical Biology.
The study also showed that the situation for these insects improved in areas where agricultural land was interspersed with natural habitats. This mixed landscape provides more diverse environments, allowing bees and other insects to thrive by offering both the resources they need and natural corridors for movement.
The research team focused on understanding how climate change and land use were specifically affecting bee populations. Summarizing their findings into three key insights, the scientists observed that warmer daytime temperatures can boost the number and diversity of bees, but only in natural habitats like forests and grasslands. This underscores the critical need to preserve and create interconnected natural areas within agricultural and urban spaces.
However, the story takes a troubling turn when it comes to warmer nights. As part of their second takeaway, the researchers found that higher night temperatures significantly reduce bee richness across all habitat types. This previously unknown impact reveals a new threat to insects, highlighting the urgency for further research to understand the physiological effects behind it.
Finally, the study revealed that climate change and land use don't affect all insects equally. Insects higher and lower in the food chain respond differently, which could disrupt food webs and important ecosystem services like pest control and pollination.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Philips launches real-time 3D intracardiac imaging in Europe, expanding access to minimally invasive heart procedures
Philips launches real-time 3D intracardiac imaging in Europe, expanding access to minimally invasive heart procedures

Business Upturn

time19-05-2025

  • Business Upturn

Philips launches real-time 3D intracardiac imaging in Europe, expanding access to minimally invasive heart procedures

By GlobeNewswire Published on May 19, 2025, 13:00 IST May 19, 2025 VeriSight Pro 3D ICE catheter is a pioneering innovation — a miniaturized ultrasound probe embedded at the tip of a thin, steerable catheter, navigated through the vascular system into the heart chambers to deliver high-quality 2D and 3D images in real time Catheter offers enhanced procedural guidance without the need for general anesthesia, supporting more efficient and patient-friendly care for structural heart disease Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of its VeriSight Pro 3D Intracardiac Echocardiography (ICE) catheter in Europe. Building on its success in the United States, VeriSight Pro brings real-time 3D imaging directly inside the heart, helping physicians perform procedures with greater clarity — without the need for general anesthesia. Designed for procedures such as transcatheter valve repair and left atrial appendage closure, VeriSight Pro offers high-resolution 2D and 3D visualization directly within the heart chambers. This enables confident clinical decision-making in structural heart and electrophysiology interventions, while removing the need for general anesthesia and associated risks. 'With VeriSight Pro 3D ICE, we now have the ability to see detailed cardiac anatomy from inside the heart in real time,' said Prof. Dr. Jörg Hausleiter, Ludwig-Maximilians-Universität (LMU) Munich, Germany. 'This helps streamline our workflows and makes complex procedures more accessible to patients who may not tolerate more invasive imaging approaches.' Addressing structural heart disease with less burden on patients and hospitals Structural heart disease is a growing challenge across Europe, with increasing volumes of transcatheter valve repair and closure procedures. Today, many of these are supported by transesophageal echocardiography (TEE), which often requires general anesthesia, additional staff, and extended room time. In contrast, 3D ICE imaging provides detailed visualization from within the heart through a catheter introduced via the femoral vein, reducing the need for general anesthesia and recovery time in the Post-Anesthesia Care Unit (PACU), which can shorten hospital stays and lower costs. VeriSight Pro is a pioneering innovation: a miniaturized ultrasound probe, approximately 3 millimeters in diameter, embedded at the tip of a thin, steerable catheter. This tiny device can be navigated through the vascular system and into the heart chambers, where it delivers high-quality 2D and 3D images in real time. Imaging the heart from within, with control over the scan angle, opens entirely new possibilities for guiding structural heart interventions. Physicians can assess anatomy, guide device placement, and confirm procedural results — all from a single access point, and without the need for more invasive imaging techniques. As the first ICE catheter to miniaturize the same 3D imaging technology used in TEE, VeriSight Pro helps address key barriers in delivering efficient, scalable care — from patient tolerance to resource availability in interventional suites. 'VeriSight Pro reflects our ongoing commitment to delivering clinically relevant innovations that enhance precision, reduce procedure complexity, and improve the care experience,' said Stacy Beske, Business Leader of Image-Guided Therapy Devices at Philips. 'Its availability in Europe is an important milestone in helping more patients benefit from image-guided, minimally invasive heart procedures, while supporting care teams with integrated solutions that adapt to the way they work.' Part of an integrated portfolio for structural heart care VeriSight Pro is part of Philips' structural heart disease ecosystem, seamlessly integrating with Philips' EPIQ ultrasound systems, which in turn integrate with the Azurion image-guided therapy platform. Combined with tools such as EchoNavigator, Philips offers an end-to-end solution for clinicians performing procedures such as tricuspid and mitral valve repair and replacement, atrial septal defect closure, and left atrial appendage occlusion. The catheter's unique features — including xPlane and iRotate technologies — allow physicians to visualize two imaging planes simultaneously and digitally adjust views without physically repositioning the catheter tip. These capabilities enable precise assessment and device deployment with fewer imaging steps. Showcasing 3D ICE in action at EuroPCR 2025 Philips will highlight VeriSight Pro and its role in structural heart interventions at EuroPCR 2025 in Paris, May 20–23. Key activities include: Physician-led symposium : 'Advanced Imaging in Structural Heart Disease Interventions' (Tuesday, May 20), featuring case insights from U.S. and European clinicians using 3D ICE and AI-assisted imaging. : (Tuesday, May 20), featuring case insights from U.S. and European clinicians using 3D ICE and AI-assisted imaging. Hands-on training village : Real-world imaging practice with VeriSight Pro on Mentice simulators, supported by Philips experts and in collaboration with Edwards Lifesciences. : Real-world imaging practice with VeriSight Pro on Mentice simulators, supported by Philips experts and in collaboration with Edwards Lifesciences. Immersive VR-based launch training: Invite-only program showcasing clinical protocols for left atrial appendage occlusion and TV TEER, including headset-based live procedure simulations. These sessions will offer clinicians an in-depth look at how 3D ICE is being applied in real-world structural heart procedures — from imaging protocols to workflow integration and clinical outcomes. A complete and detailed overview of sessions can be found here: For further information, please contact: Joost MalthaPhilips Global External RelationsTel.: +31 6 10 55 8116 E-Mail: [email protected] About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,200 employees with sales and services in more than 100 countries. News about Philips can be found at Attachment Philips VeriSight Pro 3D ICE catheter Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.

Philips launches real-time 3D intracardiac imaging in Europe, expanding access to minimally invasive heart procedures
Philips launches real-time 3D intracardiac imaging in Europe, expanding access to minimally invasive heart procedures

Hamilton Spectator

time19-05-2025

  • Hamilton Spectator

Philips launches real-time 3D intracardiac imaging in Europe, expanding access to minimally invasive heart procedures

May 19, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of its VeriSight Pro 3D Intracardiac Echocardiography (ICE) catheter in Europe. Building on its success in the United States, VeriSight Pro brings real-time 3D imaging directly inside the heart, helping physicians perform procedures with greater clarity — without the need for general anesthesia. Designed for procedures such as transcatheter valve repair and left atrial appendage closure, VeriSight Pro offers high-resolution 2D and 3D visualization directly within the heart chambers. This enables confident clinical decision-making in structural heart and electrophysiology interventions, while removing the need for general anesthesia and associated risks. 'With VeriSight Pro 3D ICE, we now have the ability to see detailed cardiac anatomy from inside the heart in real time,' said Prof. Dr. Jörg Hausleiter, Ludwig-Maximilians-Universität (LMU) Munich, Germany. 'This helps streamline our workflows and makes complex procedures more accessible to patients who may not tolerate more invasive imaging approaches.' Addressing structural heart disease with less burden on patients and hospitals Structural heart disease is a growing challenge across Europe, with increasing volumes of transcatheter valve repair and closure procedures. Today, many of these are supported by transesophageal echocardiography (TEE), which often requires general anesthesia, additional staff, and extended room time. In contrast, 3D ICE imaging provides detailed visualization from within the heart through a catheter introduced via the femoral vein, reducing the need for general anesthesia and recovery time in the Post-Anesthesia Care Unit (PACU), which can shorten hospital stays and lower costs. VeriSight Pro is a pioneering innovation: a miniaturized ultrasound probe, approximately 3 millimeters in diameter, embedded at the tip of a thin, steerable catheter. This tiny device can be navigated through the vascular system and into the heart chambers, where it delivers high-quality 2D and 3D images in real time. Imaging the heart from within, with control over the scan angle, opens entirely new possibilities for guiding structural heart interventions. Physicians can assess anatomy, guide device placement, and confirm procedural results — all from a single access point, and without the need for more invasive imaging techniques. As the first ICE catheter to miniaturize the same 3D imaging technology used in TEE, VeriSight Pro helps address key barriers in delivering efficient, scalable care — from patient tolerance to resource availability in interventional suites. 'VeriSight Pro reflects our ongoing commitment to delivering clinically relevant innovations that enhance precision, reduce procedure complexity, and improve the care experience,' said Stacy Beske, Business Leader of Image-Guided Therapy Devices at Philips. 'Its availability in Europe is an important milestone in helping more patients benefit from image-guided, minimally invasive heart procedures, while supporting care teams with integrated solutions that adapt to the way they work.' Part of an integrated portfolio for structural heart care VeriSight Pro is part of Philips' structural heart disease ecosystem, seamlessly integrating with Philips' EPIQ ultrasound systems, which in turn integrate with the Azurion image-guided therapy platform. Combined with tools such as EchoNavigator, Philips offers an end-to-end solution for clinicians performing procedures such as tricuspid and mitral valve repair and replacement, atrial septal defect closure, and left atrial appendage occlusion. The catheter's unique features — including xPlane and iRotate technologies — allow physicians to visualize two imaging planes simultaneously and digitally adjust views without physically repositioning the catheter tip. These capabilities enable precise assessment and device deployment with fewer imaging steps. Showcasing 3D ICE in action at EuroPCR 2025 Philips will highlight VeriSight Pro and its role in structural heart interventions at EuroPCR 2025 in Paris, May 20–23. Key activities include: These sessions will offer clinicians an in-depth look at how 3D ICE is being applied in real-world structural heart procedures — from imaging protocols to workflow integration and clinical outcomes. A complete and detailed overview of sessions can be found here: . For further information, please contact: Joost Maltha Philips Global External Relations Tel.: +31 6 10 55 8116 E-Mail: About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,200 employees with sales and services in more than 100 countries. News about Philips can be found at . Attachment

Study finds 65% decline in urban bee population, heat and land use are main culprits
Study finds 65% decline in urban bee population, heat and land use are main culprits

Yahoo

time12-05-2025

  • Yahoo

Study finds 65% decline in urban bee population, heat and land use are main culprits

Across the globe, the diversity of insect species and their populations are falling rapidly. A few research studies have gone as far as to estimate insect biomass has nearly halved since the 1970s. Bees are particularly hard-hit, suffering from habitat loss driven by agriculture and urban development, compounded by the growing effects of climate change. A latest study conducted by a team of scientists from Julius-Maximilians-Universität Würzburg (JMU) in Germany analyzed the combined effects of land use and rising temperatures on insects at 179 sites across Bavaria. Their research, part of the LandKlif project within the Bavarian Climate Research Network (bayklif), was led by Professor Ingolf Steffan-Dewenter, with the findings published in the Proceedings of the Royal Society B: Biological Sciences. The findings indicated that insects inhabiting different trophic levels react differently to the combination of increased temperatures and extensive land use. While bee populations in forests are able to withstand the heat, those in urban areas saw a staggering 65% decline. Similar to humans, bees are impacted not just by high daytime temperatures but also by warmer-than-average nights. According to biologist Dr. Cristina Ganuza, from the Department of Animal Ecology and Tropical Biology at JMU, the impact of night-time temperatures on diurnal insects is particularly significant. This is due to the fact that average night-time temperatures are rising faster than daytime temperatures, further stressing insect populations. Although insects higher up the food chain managed better with the heat, populations faced challenges in open agricultural habitats. "This can have a negative impact on agricultural production because insects that contribute to natural pest control should be similarly affected," said Dr. Sarah Redlich, research fellow at JMU's Department of Animal Ecology and Tropical Biology. The study also showed that the situation for these insects improved in areas where agricultural land was interspersed with natural habitats. This mixed landscape provides more diverse environments, allowing bees and other insects to thrive by offering both the resources they need and natural corridors for movement. The research team focused on understanding how climate change and land use were specifically affecting bee populations. Summarizing their findings into three key insights, the scientists observed that warmer daytime temperatures can boost the number and diversity of bees, but only in natural habitats like forests and grasslands. This underscores the critical need to preserve and create interconnected natural areas within agricultural and urban spaces. However, the story takes a troubling turn when it comes to warmer nights. As part of their second takeaway, the researchers found that higher night temperatures significantly reduce bee richness across all habitat types. This previously unknown impact reveals a new threat to insects, highlighting the urgency for further research to understand the physiological effects behind it. Finally, the study revealed that climate change and land use don't affect all insects equally. Insects higher and lower in the food chain respond differently, which could disrupt food webs and important ecosystem services like pest control and pollination.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store